Reconstructive breast implantation after mastectomy

Archives of Surgery

Volumn 141, Issue 7, 2006, Pages 714-715

  Zuckerman, Diana ^a  

^a National Research Center for Women and Families   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SILICONE GEL;

ARTICLE; AUTOIMMUNE DISEASE; BREAST AUGMENTATION; FIBROMYALGIA; FOLLOW UP; HUMAN; INFECTION COMPLICATION; MASTALGIA; MASTECTOMY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RISK FACTOR; SYMPTOM;

BREAST IMPLANTATION; BREAST IMPLANTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MASTECTOMY; PROSTHESIS DESIGN; REOPERATION; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 33746041855     PISSN: 00040010     EISSN: 15383644     Source Type: Journal    
DOI: 10.1001/archsurg.141.7.714-b     Document Type: Article

References (6)

1. Henriksen TF, Fryzek JP, Holmich LR, et al. Reconstructive breast implantation after mastectomy for breast cancer: clinical outcomes in a nationwide prospective cohort study. Arch Surg. 2005;140:1152-1159.
2. Inamed Corporation's McGhan Silicone-Filled Breast Implants, October 14-15. Food and Drug Administration Web site. http://www.fda.gov/ohrms/dockets/ ac/03/slides/3989s1_02-update_files/frame.htm. Accessed January 3, 2006.
3. Brown SL, Pennello G, Berg WA, et al. Silicone gel breast implant rupture, extracapsular silicone, and health status in a population of women. J Rheumatol. 2001;28:996-1003.
4. Summary memorandum panel. Food and Drug Administration Web site. http://www.fda.gov/ohrms/dockets/ac/05/briefing/2005-4101b1_tab-1_fda-Inamed %20Panel%20Memo.pdf. Accessed January 3, 2006.
5. Brinton LA, Lubin JH, Murray MC, et al. Mortality rates among augmentation mammoplasty patients: an update. Epidemiology. 2006;17:162-169.
6. Brinton LA, Buckley LM, Dvorkina O, et al. Risks of connective tissue disorders among breast implant patients. Am J Epidemiol. 2004;160:619-627.